• Citer

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials

par Francart, Julie;Vaes, Evelien;Henrard, Sévérine;Legrand, Catherine;Baas, Paul;Gaafar, Rabab Mohamed R.;Van Meerbeeck, Jan P A M J.P.;Sylvester, Richard J. ;Robert, Annie
Référence European journal of cancer, 45, 13, page (2304-2311)
Publication Publié, 2009-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials
Auteur:	Francart, Julie; Vaes, Evelien; Henrard, Sévérine; Legrand, Catherine; Baas, Paul; Gaafar, Rabab Mohamed R.; Van Meerbeeck, Jan P A M J.P.; Sylvester, Richard J.; Robert, Annie
Informations sur la publication:	European journal of cancer, 45, 13, page (2304-2311)
Statut de publication:	Publié, 2009-09
Sujet CREF:	Cancérologie
Mots-clés:	Clinical trials
	Cytostatic agents
	Mesothelioma
	Nomogram
	Phase II
	Prognostic index
	Progression-free survival
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2009.04.028
	info:pii/S0959804909003323
	info:scp/68749098345
	info:pmid/19502050